Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joseph Edelman currently holds 28,000 shares of Aldeyra Therapeutics, Inc. (ALDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Edelman has been a net buyer of ALDX stock. They have purchased $282.5M and sold $23.9M worth of shares.
Joseph Edelman's most recent insider trade was on Jun 23, 2026, when they sold 28,000 shares at $0.00 per share.
Joseph Edelman serves as Executive at Aldeyra Therapeutics, Inc. (ALDX). They have executed 148 insider transactions totaling $306.4M over their tenure at the company.
Joseph Edelman holds the position of Executive at Aldeyra Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Joseph Edelman has shown a buying trading pattern, with $282.5M in total purchases and $23.9M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Joseph Edelman was on Oct 25, 2021, when they purchased $23.8M worth of CRNX shares. This transaction involved 1,200,000 shares at $19.80 per share.
Joseph Edelman currently owns 28,000 shares of Aldeyra Therapeutics, Inc. (ALDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joseph Edelman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joseph Edelman has 148 Form 4 filings on record as an insider at Aldeyra Therapeutics, Inc..
Set alerts for Joseph Edelman and 40,000+ other insiders.